What do systematic reviews say?

Hyaluronic acid + hydrocolloid vs hydrocolloid dressing

The review found no eligible studies for this question.

• Dressings and topical agents containing hyaluronic acid for chronic wound healing 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Hyaluronic acid vs hydrocolloid dressing

The review found no eligible studies for this question.

• Dressings and topical agents containing hyaluronic acid for chronic wound healing 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Hyaluronic acid vs paraffin gauze

The review found no eligible studies for this question.

• Dressings and topical agents containing hyaluronic acid for chronic wound healing 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Hyaluronic acid vs neutral vehicle

The review found no eligible studies for this question.

• Dressings and topical agents containing hyaluronic acid for chronic wound healing 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Hyaluronic acid vs dextranomer

The review found no eligible studies for this question.

• Dressings and topical agents containing hyaluronic acid for chronic wound healing 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Intralesional classical immunosuppresants (betamethasone or triamcinolone) vs placebo

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Subcutaneous biologics (dupilumab) vs placebo

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Oral small molecule inhibitors (apremilast or baricitinib) vs placebo

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Oral small molecule inhibitors (ruxolitinib) vs oral small molecule inhibitors (tofacitinib)

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Topical small molecule inhibitors (ruxolitinib) vs placebo

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Contact immunotherapy (diphencyprone or squaric acid dibutil ester) vs placebo

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Contact immunotherapy (diphencyprone or squaric acid dibutil ester) vs hair growth stimulants (minoxidil)

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Contact immunotherapy (diphencyprone) + hair growth stimulants (minoxidil) vs contact immunotherapy (diphencyprone)

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Minoxidil vs placebo

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Other therapies (cryotherapy) vs other therapies (fractional CO2 laser)

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Oral classical immunosuppressants (betamethasone) vs oral classical immunosuppressants (azathioprine, methotrexate, prednisolone)

The review found no eligible studies for this question.

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Nonabsorbable tacks vs fibrin sealant

• Mesh fixation techniques in primary ventral or incisional hernia repair 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 50 participants
  Low

Absorbable tacks vs fibrin sealant

• Mesh fixation techniques in primary ventral or incisional hernia repair 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 50 participants
  Low

Phaco‐AIT vs Phaco‐Trab

The review found no eligible studies for this question.

• Ab interno trabecular bypass surgery with Trabectome for open‐angle glaucoma 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Phacoemulsification + supraciliary microstent surgery vs phacoemulsification alone

The review found no eligible studies for this question.

• Ab interno supraciliary microstent surgery for open‐angle glaucoma 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found